Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7431 p728
16 December 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
NES Pharmacy


NES explains new preregistration scheme

New arrangements for preregistration training in Scotland will be in place in time for next year's applications.

The intention to create a national scheme co-ordinated by NHS Education for Scotland (NES) was announced earlier this year (PJ, 23 September, p359). This week, Rose Marie Parr, director of NES Pharmacy, told The Journal that the scheme has now been approved by the NES board. NES is getting ready to receive the first applications through the scheme in spring.

Under the scheme — known as the NHS Pre-Registration Pharmacist Scheme (PRPS) — NES will control the organisation, administration and funding of preregistration placements in hospital and community pharmacy. All placements will involve a similar programme including at least eight weeks of cross-sectoral experience and national study days. Tutors will also receive support. Funding will include a grant to cover the preregistration salary (based on Agenda for Change) and employer costs.

In a statement, NES said: “It is not known which of the community employers will be joining the scheme, though it is very much hoped that all will want to take part. Any community employers not wishing to be part of the scheme can still provide preregistration training but they will not receive the grant or benefit from the support structures being put in place. It is expected that the scheme will recruit the same number of preregistration pharmacists as have been trained in previous years in Scotland — around 160.”

Application packs for PRPS placements in 2008–09 will be available from NES from spring 2007. The deadline for applications will be 11 June 2007, with interviews taking place in September 2007. Selection will be organised by NES and involve a panel of interviewers from hospital and community practice.

Back to Top


©The Pharmaceutical Journal